The abstract submission will open in January 2025
Abstract submission deadlines
Deadline |
Date and time |
|---|---|
|
Abstracts Trial in Progress |
Tuesday, 1 April 2025, 21:00 CEST (Central European Summer Time) |
Abstract submission categories
- Basic and translational research
- Cervical cancer
- Endometrial cancer
- Ovarian cancer
- Miscellaneous
Outcome notifications
Outcome notifications of regular abstracts are expected to be made available to first authors and submitters by late April 2025.
Presentation and publication of accepted abstracts
The ESMO Gynaecological Cancers Congress 2025 Scientific Committee will select abstracts for presentation during the Congress and determine the format of the presentations from the following possibilities:
- Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
- Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
- Poster – Display session for review, discussion and questions. The presenting authors must be available for Q&A to represent their work.
All accepted abstracts, will be published online in the ESMO Gynaecological Cancers Congress 2025 Abstract Book, a supplement to the official ESMO journal, ESMO Open.
Publication schedule of accepted abstracts
Abstracts accepted for presentation during the ESMO Gynaecological Cancers Congress 2025 Congress will be released online according to a schedule which will be available on the ESMO website in due time.
ESMO Merit Travel Grant
A restricted number of ESMO Merit Travel Grants to the ESMO Gynaecological Cancers Congress 2025 are available, upon application, to first author (= presenter) who submit abstracts considered to be deserving of recognition. Candidates must be ESMO Members under the age of 40. Selection will be made by the ESMO Gynaecological Cancers Congress 2025 Scientific Committee on a competitive basis from among the accepted abstracts.